Composition:

Nanosilver

Indications:

Viral infections in dogs and cats (Distemper non-neurological, Parvovirus, FIP, Panleucopenia).

Principles of action:

Many diseases thrive in environments where cells are low in oxygen. Colloidal silver acts as a transporter of oxygen to cells in the body. When it comes into contact with pathogenic cells in a low oxygen environment, it releases the oxygen it’s carrying and damages the cell wall of the pathogen.

It is so powerful that not only does it inhibit both RNA and DNA replication of pathogen cells, it also cuts off the ability for the pathogen cell to metabolise. All the while, doing no damage to healthy cells or essential metabolic processes in the body. Unlike many chemical substances antivirals, antibiotics, etc. colloidal silver doesn’t destroy the microbiome in the blood and digestive system or consequently affect the mitochondria fundamental to the proper functions of the organs.

The mechanism of action of AgNPs as antiviral agent has been studied against several enveloped viruses. It has been proposed that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs. Owing to this interaction, silver nanoparticles inhibit the virus from binding to host cells. Other studies also showed that AgNPs inhibit arenavirus replication during the early phases of viral replication. AgNPs inhibits influenza virus interfering with the fusion of the viral membrane, inhibiting viral penetration into the host cell. CDV has an enveloped virion containing RNA. It has two glycoproteins (haemagglutinin H and fusion protein F).CDV uses protein H for attachment to receptors on the cell in the first step of infection. After attachment, F protein promotes fusion of cell membrane with viral envelope.